Amends the provisions governing the reimbursement methodology in the Pharmacy Benefits Management Program in order to clarify requirements regarding 340B-covered entities, and to revise the reimbursement methodology to include federal upper limits (FUL), new copayment exemptions and over-the-counter medications added for expansion benefits pursuant to U.S. Department of Health and Human Services, Centers for Medicare and Medicaid Services (CMS) recently released regulations.
Contact Information: Jen Steele, Bureau of Health Services Financing, P.O. Box 91030, Baton Rouge, LA 70821-9030
.Act 401 Compliance: The Notices of Intent pages were developed in accordance with ACT 401 of the 2014 Louisiana Legislative Session.
Disclaimer: Please note that the official versions of the Notices of Intent are maintained by the Office of State Register’s website at http://www.doa.louisiana.gov/osr/osr.htm. The excerpted versions of these Notices of Intent contained on this website are provided as a courtesy service to the public and is unofficial and should not be regarded as such. Users are encouraged to visit the Office of State Register’s website for the official version.
- Emergency Rule: N/A
- Notice of Intent: Prior to Proposed Rule: November 2016 LAC
- Notice of Intent: Proposed Rule
- Notice of Intent: January 20, 2017 (Louisiana Register)
- Public Hearing: February 27, 2017
- Oversight Report: N/A
- Oversight Hearing: N/A
- Final Rule: N/A